Local News Channel Honors Deceased Weatherman with Prostate Cancer Awareness Campaign

0
(0)

Cincinnati, Ohio news channel Local 12 has engaged in a prostate cancer awareness campaign after the death of weatherman Tim Hedrick. The man who became known as “The Weather Authority” had been diagnosed with prostate cancer eight years ago, and he died last month at the age of 55, due to complications related to the malignant disease.

While Hedrick’s family, colleagues, and fans mourn the loss, the channel decided to use the moment to make a series of videos and articles about the topic. The idea is not only to increase knowledge about the disease – which is the second most common type of cancer among American men – but also to encourage all men to get tested regularly and be watchful about their prostates’ health.

In this video, the team visited the Trihealth services in Cincinnati and talked with the urologist Dr. Mark Delworth about prostate cancer. The physician believes that what is most important for people to understand is that the disease is different for every patient. “A lot of prostate cancer is slow growing, but it’s just like any other type of disease process, there’s a vast spectrum. So while a lot of it is slow growing there is a moderate and a very aggressive form,” said Dr. Delworth.

“Sometimes if we have a disease that’s not curable, our goal is to have someone live with that disease process, and then maybe die of something else,” he added. In addition, the urologist also emphasized the important of knowing the family history and discussing the risks with the health care provider. It is also recommended that men take a prostate-specific antigen (PSA) test regularly, which is a simple blood test that can widely increase the chances of detecting the disease early.

Learn more about prostate cancer: http://bit.ly/1MlKABv

Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *